Position in PRGO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$133,106
-$4,484 QoQ
Shares Held
12,811
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#218
of 334 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CIBC Asset Management Inc holds $28,653,269 across 17 Drug Manufacturers - Specialty & Generic names. PRGO ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
119,627 | $8,596,396 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
159,286 | $5,396,609 | |
| 3 | VTRS |
Viatris Inc
|
255,729 | $4,060,976 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,285 | $3,405,401 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
19,103 | $3,219,619 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
265,310 | $1,307,978 | |
| 7 | HLN |
Haleon plc
|
60,500 | $564,465 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
15,695 | $386,253 |
All Filings in PRGO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,106 | 12,811 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $137,590 | 12,811 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $183,326 | 13,170 | Shares | Sole | 2026-02-10 | |
| 2021-06-30 | $302,243 | 6,592 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $267,709 | 6,615 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $294,302 | 6,581 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $302,133 | 6,581 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $363,731 | 6,581 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $307,150 | 6,387 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||